Moreover, to study the mechanism of activation of the Shh signaling in thyroid cancer cells and to verify whether the signaling is mediated by the membrane receptor Smo, we took advantage of using the drug cyclopamine, a commercially available Smo inhibitor. Here, SMO is linked to thyroid cancer.